Lara Jungvig

1.0k total citations
9 papers, 708 citations indexed

About

Lara Jungvig is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Lara Jungvig has authored 9 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cell Biology. Recurrent topics in Lara Jungvig's work include Pharmacology and Obesity Treatment (4 papers), Hormonal and reproductive studies (3 papers) and Muscle metabolism and nutrition (3 papers). Lara Jungvig is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), Hormonal and reproductive studies (3 papers) and Muscle metabolism and nutrition (3 papers). Lara Jungvig collaborates with scholars based in United States. Lara Jungvig's co-authors include Marika J Suttorp, Mary Hardy, Sally C. Morton, Paul G Shekelle, Shannon Rhodes, Margaret Maglione, Walter Mojica, PG Shekelle, Sydne J Newberry and Jay Udani and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Journal of General Internal Medicine.

In The Last Decade

Lara Jungvig

9 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Jungvig United States 9 241 150 140 129 92 9 708
Nouri Mensi Switzerland 8 126 0.5× 78 0.5× 337 2.4× 136 1.1× 89 1.0× 8 991
M.U.R. Naidu India 19 245 1.0× 169 1.1× 181 1.3× 68 0.5× 27 0.3× 55 1.2k
Philippe Chantre France 7 129 0.5× 83 0.6× 221 1.6× 88 0.7× 84 0.9× 8 968
Seyfullah Oktay Arslan Türkiye 15 111 0.5× 127 0.8× 171 1.2× 59 0.5× 26 0.3× 50 927
Majid Mohammadshahi Iran 18 89 0.4× 91 0.6× 202 1.4× 200 1.6× 41 0.4× 46 906
Siamak Bidel Finland 15 487 2.0× 102 0.7× 218 1.6× 78 0.6× 27 0.3× 19 1.4k
Karin Kraft Germany 17 65 0.3× 167 1.1× 91 0.7× 193 1.5× 28 0.3× 90 932
Junkuan Wang China 15 100 0.4× 74 0.5× 182 1.3× 198 1.5× 33 0.4× 24 1.1k
Abasalt Borji Iran 19 171 0.7× 188 1.3× 105 0.8× 77 0.6× 17 0.2× 37 1.1k
Daniela Zanini Brazil 18 143 0.6× 72 0.5× 257 1.8× 82 0.6× 21 0.2× 44 1.0k

Countries citing papers authored by Lara Jungvig

Since Specialization
Citations

This map shows the geographic impact of Lara Jungvig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Jungvig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Jungvig more than expected).

Fields of papers citing papers by Lara Jungvig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Jungvig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Jungvig. The network helps show where Lara Jungvig may publish in the future.

Co-authorship network of co-authors of Lara Jungvig

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Jungvig. A scholar is included among the top collaborators of Lara Jungvig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Jungvig. Lara Jungvig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Maglione, Margaret, Karen Miotto, Martin Y. Iguchi, et al.. (2004). Psychiatric Effects of Ephedra Use: An Analysis of Food and Drug Administration Reports of Adverse Events. American Journal of Psychiatry. 162(1). 189–191. 31 indexed citations
2.
Shekelle, Paul G, Sally C. Morton, Lara Jungvig, et al.. (2004). Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. Journal of General Internal Medicine. 19(4). 380–389. 103 indexed citations
3.
MacLean, Catherine H., James Pencharz, Rena Hasenfeld Garland, et al.. (2004). Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis.. PubMed. 1–4. 87 indexed citations
4.
Shekelle, Paul G, Mary Hardy, Sally C. Morton, et al.. (2003). Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance. JAMA. 289(12). 1537–1537. 339 indexed citations
5.
Shekelle, Paul G, Mary Hardy, Sally C. Morton, et al.. (2003). Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance. JAMA. 289(12). 1537–1537. 11 indexed citations
6.
Shekelle, PG, Mary Hardy, Ian D. Coulter, et al.. (2003). Effect of the supplemental use of antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cancer.. PubMed. 1–3. 12 indexed citations
7.
Shekelle, Paul, Suzanne Morton, Simon J. Atkinson, et al.. (2003). Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness.. PubMed. 1–6. 17 indexed citations
8.
Shekelle, Paul, Margaret Maglione, Marika J Suttorp, et al.. (2003). Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.. PubMed. 1–4. 49 indexed citations
9.
Hardy, Mary, Ivan S. Coulter, Swamy R. Venuturupalli, et al.. (2003). S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.. PubMed. 1–3. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026